Latest University of Massachusetts Medical School Stories
Landmark international study of more than 60,000 women highlights need for public education about osteoporosis risk factors and treatment.
UMass Medical School neurobiologists use transgenic fruit flies and monarch butterfly transgenes to help define magnetoreception mechanism.
Results of phase 2 clinical trial testing novel antibodies to treat clostridium difficile infection published in the New England Journal of Medicine.
IRVINE, Calif., Oct.
CHICAGO and WORCESTER, Mass., Oct.
The University of Massachusetts Medical School says it's taking part in testing a human monoclonal antibody developed to neutralize the rabies virus. The clinical trial being conducted in Mumbai, India, is sponsored by the Serum Institute of India, which is working with the university's Massachusetts Biologic Laboratories that is manufacturing the new antibody. India is an appropriate location to do this study because of the serious problem of rabies that exists in the country, said Dr.
MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody (MAB) developed to neutralize the rabies virus.
After years of theorizing about how Monarch butterflies find their way to Mexico for the winter, scientists have finally discovered that their antennas help them navigate the journey.
WOODS HOLE, Mass., Sept.
Building upon a series of successful preclinical studies, researchers at MassBiologics of the University of Massachusetts Medical School (UMMS) today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody they developed that can neutralize the Hepatitis C virus (HCV).
- The governor of a province or people.